# FDA Inspection 1254722 - Biomat USA Inc. - November 14, 2024

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/8063a20e-0f94-4a70-b5da-30f5eb4f89df
Source feed: FDA_Inspections

> FDA Inspection 1254722 for Biomat USA Inc. on November 14, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1254722
- Company Name: Biomat USA Inc.
- Inspection Date: 2024-11-14
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1254722 - 2024-11-14](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/6853893e-44eb-4799-a009-f48bfe63efc0)
- [FDA Inspection 1106925 - 2019-09-24](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/c95126ba-6c2f-42f3-b272-a638dfa17e4c)
- [FDA Inspection 941867 - 2015-09-09](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/30bd8d44-052a-4964-98eb-2542ad26cf42)
- [FDA Inspection 820529 - 2013-02-21](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/e784e26f-4fa4-4cd7-818f-534e3f610de3)

Company: https://www.keypedia.com/companies/biomat-usa-inc/60678e3e-a026-4a4a-99ad-f20a3d19f60d

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d